Diagnostic performance of contrast-enhanced CT combined with contrast-enhanced MRI for colorectal liver metastases: a case-control study
- PMID: 40114056
- PMCID: PMC11924653
- DOI: 10.1186/s12876-025-03785-3
Diagnostic performance of contrast-enhanced CT combined with contrast-enhanced MRI for colorectal liver metastases: a case-control study
Abstract
Background: Colorectal liver metastases (CRLM) are a major determinant of prognosis in colorectal cancer (CRC) patients. Their early and accurate detection is essential for appropriate therapeutic planning and improving survival outcomes.
Purpose: To evaluate the diagnostic capabilities of contrast-enhanced computed tomography (CT) and contrast-enhanced magnetic resonance imaging (MRI) in detecting colorectal liver metastases.
Materials and methods: We employed a case-control design to compare patients with histologically confirmed liver metastases against a control group without the condition. A total of 85 patients in each group were selected and retrospectively matched based on relevant factors. All subjects underwent both contrast-enhanced CT and MRI. The diagnostic performance of these imaging modalities was assessed by analysing sensitivity, specificity, positive and negative predictive values, and radiologists' diagnostic confidence. Kappa statistics were used to evaluate inter-observer agreement. All MRI scans were performed using a 3-Tesla (3-T) MRI scanner to ensure high-quality imaging and detailed lesion characterization. And all the scans were reviewed by two radiologists.
Results: The combination of contrast-enhanced CT and MRI demonstrated a statistically significant improvement in sensitivity (90.6% for MRI alone vs. 96.5% for combined modalities) and specificity (95.3% for MRI alone vs. 98.3% for combined modalities). Positive and negative predictive values were similarly enhanced. Radiologists' diagnostic confidence was higher with combined imaging, achieving a 'very high' confidence level in 78.8% of cases compared with 64.7% for MRI alone. The inter-observer agreement reached 'almost perfect' status with the combined approach.
Conclusion: The integration of contrast-enhanced CT with MRI significantly enhanced the diagnostic accuracy for colorectal liver metastases, representing a valuable tool for the preoperative evaluation of patients with CRC.
Clinical trial number: Not applicable.
Keywords: Colorectal cancer; Computed tomography; Contrast-enhanced MRI; Diagnostic imaging; Liver metastases; Magnetic resonance imaging.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: The Ethics Committee of Zhongshan Hospital Xiamen University, Xiamen City, Fujian Province, China approved the study. All participants were provided with a written informed consent form, clearly stating that their participation in the study was voluntary and that they had the right to withdraw at any time without facing any consequences. The participants guardians were provided with detailed explanations about the confidentiality of their information. Written informed consent was obtained from all participants. All methods were carried out in accordance with relevant guidelines and regulations. Consent for publication: None. Competing interests: The authors declare no competing interests.
Figures





Similar articles
-
Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases.Invest Radiol. 2011 Sep;46(9):548-55. doi: 10.1097/RLI.0b013e31821a2163. Invest Radiol. 2011. PMID: 21577131
-
Incremental value of liver MR imaging in patients with potentially curable colorectal hepatic metastasis detected at CT: a prospective comparison of diffusion-weighted imaging, gadoxetic acid-enhanced MR imaging, and a combination of both MR techniques.Radiology. 2015 Mar;274(3):712-22. doi: 10.1148/radiol.14140390. Epub 2014 Oct 3. Radiology. 2015. PMID: 25286324
-
Diagnostic accuracy of CE-CT, MRI and FDG PET/CT for detecting colorectal cancer liver metastases in patients considered eligible for hepatic resection and/or local ablation.Eur Radiol. 2018 Nov;28(11):4735-4747. doi: 10.1007/s00330-018-5469-0. Epub 2018 May 7. Eur Radiol. 2018. PMID: 29736846
-
CEUS compared with CECT, MRI, and FDG-PET/CT for diagnosing CRC liver metastases: a diagnostic test accuracy systematic review and meta-analysis.Expert Rev Gastroenterol Hepatol. 2024 Sep;18(9):541-549. doi: 10.1080/17474124.2024.2407973. Epub 2024 Sep 25. Expert Rev Gastroenterol Hepatol. 2024. PMID: 39315472
-
Diagnostic performance of CT, gadoxetate disodium-enhanced MRI, and PET/CT for the diagnosis of colorectal liver metastasis: Systematic review and meta-analysis.J Magn Reson Imaging. 2018 May;47(5):1237-1250. doi: 10.1002/jmri.25852. Epub 2017 Sep 13. J Magn Reson Imaging. 2018. PMID: 28901685
Cited by
-
Assessment prior to liver tumor resection: what a radiologist needs to know.Abdom Radiol (NY). 2025 Jun 23. doi: 10.1007/s00261-025-05078-5. Online ahead of print. Abdom Radiol (NY). 2025. PMID: 40549181 Review.
References
-
- Niekel M, Bipat S, Stoker J. Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment. Radiology 2010;257(674– 84). - PubMed
-
- Floriani I, Torri V, Rulli E. Performance of imaging modalities in diagnosis of liver metastases from colorectal cancer: a systematic review and meta-analysis. J Magn Reson Imaging. 2010;31:19–31. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical